{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:55:29Z","timestamp":1775019329546,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T00:00:00Z","timestamp":1466121600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00392-016-1009-6","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T02:53:34Z","timestamp":1466132014000},"page":"971-980","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure"],"prefix":"10.1007","volume":"105","author":[{"given":"Shiro","family":"Ishihara","sequence":"first","affiliation":[]},{"given":"Etienne","family":"Gayat","sequence":"additional","affiliation":[]},{"given":"Naoki","family":"Sato","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4028-2869","authenticated-orcid":false,"given":"Mattia","family":"Arrigo","sequence":"additional","affiliation":[]},{"given":"Said","family":"Laribi","sequence":"additional","affiliation":[]},{"given":"Matthieu","family":"Legrand","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Placido","sequence":"additional","affiliation":[]},{"given":"Philippe","family":"Manivet","sequence":"additional","affiliation":[]},{"given":"Alain","family":"Cohen-Solal","sequence":"additional","affiliation":[]},{"given":"William T.","family":"Abraham","sequence":"additional","affiliation":[]},{"given":"Mariell","family":"Jessup","sequence":"additional","affiliation":[]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,6,17]]},"reference":[{"issue":"4","key":"1009_CR1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11897-011-0071-7","volume":"8","author":"M Dupont","year":"2011","unstructured":"Dupont M, Mullens W, Tang WH (2011) Impact of systemic venous congestion in heart failure. Curr Heart Fail Rep 8(4):233\u2013241","journal-title":"Curr Heart Fail Rep"},{"issue":"10","key":"1009_CR2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/eurheartj\/ehs332","volume":"34","author":"M Nikolaou","year":"2013","unstructured":"Nikolaou M, Parissis J, Yilmaz MB, Seronde MF, Kivikko M, Laribi S, Paugam-Burtz C, Cai D, Pohjanjousi P, Laterre PF, Deye N, Poder P, Cohen-Solal A, Mebazaa A (2013) Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure. Eur Heart J 34(10):742\u2013749","journal-title":"Eur Heart J"},{"issue":"4","key":"1009_CR3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00134-010-2113-0","volume":"37","author":"F Follath","year":"2011","unstructured":"Follath F, Yilmaz MB, Delgado JF, Parissis JT, Porcher R, Gayat E, Burrows N, McLean A, Vilas-Boas F, Mebazaa A (2011) Clinical presentation, management and outcomes in the acute heart failure global survey of standard treatment (ALARM-HF). Intensive Care Med 37(4):619\u2013626","journal-title":"Intensive Care Med"},{"issue":"3","key":"1009_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1\u201348","journal-title":"J Stat Softw"},{"issue":"4","key":"1009_CR5","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/oxfordjournals.eurheartj.a060538","volume":"15","author":"C Albo","year":"1994","unstructured":"Albo C, Saal JP, Lellouche D, Habbal R, Benvenuti C, Deleuze P, Loisance D, Castaigne A, Dubois-Rande JL (1994) Additive haemodynamic effects of piroximone and prostacyclin in severe chronic heart failure. Eur Heart J 15(4):528\u2013533","journal-title":"Eur Heart J"},{"issue":"13","key":"1009_CR6","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","volume":"294","author":"C Binanay","year":"2005","unstructured":"Binanay C, Califf RM, Hasselblad V, O\u2019Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW, Investigators E, Coordinators ES (2005) Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294(13):1625\u20131633","journal-title":"JAMA"},{"issue":"4","key":"1009_CR7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM200007273430403","volume":"343","author":"WS Colucci","year":"2000","unstructured":"Colucci WS, Elkayam U, Horton DP, Abraham WT, Bourge RC, Johnson AD, Wagoner LE, Givertz MM, Liang CS, Neibaur M, Haught WH, LeJemtel TH (2000) Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 343(4):246\u2013253","journal-title":"N Engl J Med"},{"issue":"5","key":"1009_CR8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ejheart.2004.05.004","volume":"6","author":"G Cotter","year":"2004","unstructured":"Cotter G, Kaluski E, Stangl K, Pacher R, Richter C, Milo-Cotter O, Perchenet L, Kobrin I, Kaplan S, Rainisio M, Frey A, Neuhart E, Vered Z, Dingemanse J, Torre-Amione G (2004) The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A\/B receptor antagonist) in patients with acute heart failure. Eur J Heart Fail 6(5):601\u2013609","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"1009_CR9","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/CIRCHEARTFAILURE.112.968511","volume":"5","author":"M Dupont","year":"2012","unstructured":"Dupont M, Mullens W, Skouri HN, Abrahams Z, Wu Y, Taylor DO, Starling RC, Tang WH (2012) Prognostic role of pulmonary arterial capacitance in advanced heart failure. Circ Heart Fail. 5(6):778\u2013785","journal-title":"Circ Heart Fail."},{"issue":"1","key":"1009_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehs196","volume":"34","author":"E Erdmann","year":"2013","unstructured":"Erdmann E, Semigran MJ, Nieminen MS, Gheorghiade M, Agrawal R, Mitrovic V, Mebazaa A (2013) Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure. Eur Heart J 34(1):57\u201367","journal-title":"Eur Heart J"},{"issue":"11","key":"1009_CR11","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/oxfordjournals.eurheartj.a060099","volume":"13","author":"HH Erlemeier","year":"1992","unstructured":"Erlemeier HH, Kupper W, Bleifeld W (1992) Effect of dobutamine on pulmonary gas exchange in patients with severe heart failure. Eur Heart J 13(11):1545\u20131548","journal-title":"Eur Heart J"},{"issue":"3","key":"1009_CR12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0735-1097(85)80402-2","volume":"5","author":"MA Fifer","year":"1985","unstructured":"Fifer MA, Colucci WS, Lorell BH, Jaski BE, Barry WH (1985) Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside. J Am Coll Cardiol 5(3):731\u2013737","journal-title":"J Am Coll Cardiol"},{"issue":"9328","key":"1009_CR13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","volume":"360","author":"F Follath","year":"2002","unstructured":"Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L, Steering C (2002) Investigators of the Levosimendan Infusion versus Dobutamine S. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360(9328):196\u2013202","journal-title":"Lancet"},{"issue":"1","key":"1009_CR14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/CCM.0b013e31819290d5","volume":"37","author":"S Friesecke","year":"2009","unstructured":"Friesecke S, Heinrich A, Abel P, Felix SB (2009) Comparison of pulmonary artery and aortic transpulmonary thermodilution for monitoring of cardiac output in patients with severe heart failure: validation of a novel method. Crit Care Med 37(1):119\u2013123","journal-title":"Crit Care Med"},{"issue":"23","key":"1009_CR15","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.jacc.2008.03.015","volume":"51","author":"M Gheorghiade","year":"2008","unstructured":"Gheorghiade M, Blair JE, Filippatos GS, Macarie C, Ruzyllo W, Korewicki J, Bubenek-Turconi SI, Ceracchi M, Bianchetti M, Carminati P, Kremastinos D, Valentini G, Sabbah HN, Investigators H-H (2008) Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure. J Am Coll Cardiol 51(23):2276\u20132285","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1009_CR16","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/eurjhf\/hfs093","volume":"14","author":"M Gheorghiade","year":"2012","unstructured":"Gheorghiade M, Greene SJ, Filippatos G, Erdmann E, Ferrari R, Levy PD, Maggioni A, Nowack C, Mebazaa A, Investigators C (2012) Coordinators. Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes. Eur J Heart Fail 14(9):1056\u20131066","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"1009_CR17","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0735-1097(86)80231-5","volume":"7","author":"R Grose","year":"1986","unstructured":"Grose R, Strain J, Greenberg M, LeJemtel TH (1986) Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure. J Am Coll Cardiol 7(5):1107\u20131113","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1009_CR18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/clc.20831","volume":"34","author":"M Guglin","year":"2011","unstructured":"Guglin M, Rivero A, Matar F, Garcia M (2011) Renal dysfunction in heart failure is due to congestion but not low output. Clin Cardiol 34(2):113\u2013116","journal-title":"Clin Cardiol"},{"issue":"2","key":"1009_CR19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijcard.2007.12.106","volume":"134","author":"F Knebel","year":"2009","unstructured":"Knebel F, Schimke I, Diaz Ramirez I, Schattke S, Eddicks S, Borges AC, Baumann G (2009) Hemodynamic improvement of acutely decompensated heart failure patients is associated with decreasing levels of NT-proBNP. Int J Cardiol 134(2):260\u2013263","journal-title":"Int J Cardiol"},{"issue":"5 Suppl","key":"1009_CR20","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.cardfail.2005.04.012","volume":"11","author":"F Knebel","year":"2005","unstructured":"Knebel F, Schimke I, Pliet K, Schattke S, Martin S, Borges AC, Baumann G (2005) NT-ProBNP in acute heart failure: correlation with invasively measured hemodynamic parameters during recompensation. J Card Fail 11(5 Suppl):S38\u2013S41","journal-title":"J Card Fail"},{"issue":"7","key":"1009_CR21","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1253\/circj.CJ-12-0033","volume":"76","author":"S Kobayashi","year":"2012","unstructured":"Kobayashi S, Susa T, Tanaka T, Murakami W, Fukuta S, Okuda S, Doi M, Wada Y, Nao T, Yamada J, Okamura T, Yano M, Matsuzaki M (2012) Low-dose beta-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure. Circ J 76(7):1646\u20131653","journal-title":"Circ J"},{"issue":"1","key":"1009_CR22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0002-8703(95)90050-0","volume":"129","author":"T Masuyama","year":"1995","unstructured":"Masuyama T, Lee JM, Nagano R, Nariyama K, Yamamoto K, Naito J, Mano T, Kondo H, Hori M, Kamada T (1995) Doppler echocardiographic pulmonary venous flow-velocity pattern for assessment of the hemodynamic profile in acute congestive heart failure. Am Heart J 129(1):107\u2013113","journal-title":"Am Heart J"},{"issue":"1","key":"1009_CR23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0735-1097(99)00184-9","volume":"34","author":"RM Mills","year":"1999","unstructured":"Mills RM, LeJemtel TH, Horton DP, Liang C, Lang R, Silver MA, Lui C, Chatterjee K (1999) Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group. J Am Coll Cardiol 34(1):155\u2013162","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"1009_CR24","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/eurheartj\/ehl337","volume":"27","author":"V Mitrovic","year":"2006","unstructured":"Mitrovic V, Seferovic PM, Simeunovic D, Ristic AD, Miric M, Moiseyev VS, Kobalava Z, Nitsche K, Forssmann WG, Luss H, Meyer M (2006) Haemodynamic and clinical effects of ularitide in decompensated heart failure. Eur Heart J 27(23):2823\u20132832","journal-title":"Eur Heart J"},{"issue":"2","key":"1009_CR25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1536\/ihj.52.114","volume":"52","author":"T Mizutani","year":"2011","unstructured":"Mizutani T, Inomata T, Watanabe I, Maekawa E, Yanagisawa T, Shinagawa H, Koitabashi T, Takeuchi I, Izumi T (2011) Comparison of nitrite compounds and carperitide for initial treatment of acute decompensated heart failure. Int Heart J. 52(2):114\u2013118","journal-title":"Int Heart J."},{"issue":"3 Pt 2","key":"1009_CR26","first-page":"168","volume":"73","author":"ES Monrad","year":"1986","unstructured":"Monrad ES, Baim DS, Smith HS, Lanoue AS (1986) Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. Circulation 73(3 Pt 2):168\u2013174 (III)","journal-title":"Circulation"},{"issue":"3","key":"1009_CR27","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2008.02.083","volume":"52","author":"W Mullens","year":"2008","unstructured":"Mullens W, Abrahams Z, Francis GS, Skouri HN, Starling RC, Young JB, Taylor DO, Tang WH (2008) Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol 52(3):200\u2013207","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"1009_CR28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","volume":"53","author":"W Mullens","year":"2009","unstructured":"Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53(7):589\u2013596","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1009_CR29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ahj.2004.05.051","volume":"149","author":"JO O\u2019Neill","year":"2005","unstructured":"O\u2019Neill JO, Bott-Silverman CE, McRae AT 3rd, Troughton RW, Ng K, Starling RC, Young JB (2005) B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure. Am Heart J 149(2):363\u2013369","journal-title":"Am Heart J"},{"issue":"7","key":"1009_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00392-016-1009-6","volume":"35","author":"P Ponikowski","year":"2014","unstructured":"Ponikowski P, Mitrovic V, Ruda M, Fernandez A, Voors AA, Vishnevsky A, Cotter G, Milo O, Laessing U, Zhang Y, Dahlke M, Zymlinski R, Metra M (2014) A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure. Eur Heart J 35(7):431\u2013441. doi: 10.1007\/s00392-016-1009-6","journal-title":"Eur Heart J"},{"issue":"12","key":"1009_CR31","first-page":"1531","volume":"287","author":"Committee for the VI. Publication","year":"2002","unstructured":"Committee for the VI. Publication (2002) Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 287(12):1531\u20131540","journal-title":"JAMA"},{"issue":"4","key":"1009_CR32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1378\/chest.84.4.408","volume":"84","author":"M Renard","year":"1983","unstructured":"Renard M, Jacobs P, Dechamps P, Dresse A, Bernard R (1983) Hemodynamic and clinical response to three-day infusion of sulmazol (AR-L 115 BS) in severe congestive heart failure. Chest 84(4):408\u2013413","journal-title":"Chest"},{"issue":"4","key":"1009_CR33","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/cc7994","volume":"13","author":"S Ritter","year":"2009","unstructured":"Ritter S, Rudiger A, Maggiorini M (2009) Transpulmonary thermodilution-derived cardiac function index identifies cardiac dysfunction in acute heart failure and septic patients: an observational study. Crit Care 13(4):R133","journal-title":"Crit Care"},{"issue":"5","key":"1009_CR34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF01720906","volume":"20","author":"JP Saal","year":"1994","unstructured":"Saal JP, Habbal R, Estagnasie P, Lellouche D, Castaigne A, Dubois-Rande JL (1994) Effects of piroximone on the right ventricular function in severe heart failure patients. Intensive Care Med 20(5):341\u2013347","journal-title":"Intensive Care Med"},{"issue":"9","key":"1009_CR35","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/00003246-199609000-00010","volume":"24","author":"Y Seino","year":"1996","unstructured":"Seino Y, Momomura S, Takano T, Hayakawa H, Katoh K (1996) Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan. Japan Intravenous Milrinone Investigators. Crit Care Med 24(9):1490\u20131497","journal-title":"Crit Care Med"},{"issue":"18","key":"1009_CR36","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/01.CIR.102.18.2222","volume":"102","author":"MT Slawsky","year":"2000","unstructured":"Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Hutchins S, Leier CV, LeJemtel TH, Loh E, Nicklas J, Ogilby D, Singh BN, Smith W (2000) Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation 102(18):2222\u20132227","journal-title":"Circulation"},{"issue":"3","key":"1009_CR37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jjcc.2010.06.009","volume":"56","author":"K Tanaka","year":"2010","unstructured":"Tanaka K, Kato K, Takano T, Katagiri T, Asanoi H, Nejima J, Nakashima M, Kamijo T, Sakanashi M (2010) Acute effects of intravenous nicorandil on hemodynamics in patients hospitalized with acute decompensated heart failure. J Cardiol 56(3):291\u2013299","journal-title":"J Cardiol"},{"issue":"1","key":"1009_CR38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0735-1097(03)00556-4","volume":"42","author":"G Torre-Amione","year":"2003","unstructured":"Torre-Amione G, Young JB, Colucci WS, Lewis BS, Pratt C, Cotter G, Stangl K, Elkayam U, Teerlink JR, Frey A, Rainisio M, Kobrin I (2003) Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 42(1):140\u2013147","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1009_CR39","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1186\/cc11440","volume":"16","author":"JL Zilinski","year":"2012","unstructured":"Zilinski JL, Shah RV, Gaggin HK, Gantzer ML, Wang TJ, Januzzi JL (2012) Measurement of multiple biomarkers in advanced stage heart failure patients treated with pulmonary artery catheter guided therapy. Crit Care 16(4):R135","journal-title":"Crit Care"},{"issue":"2","key":"1009_CR40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00134-003-2025-3","volume":"30","author":"A Mebazaa","year":"2004","unstructured":"Mebazaa A, Karpati P, Renaud E, Algotsson L (2004) Acute right ventricular failure\u2013from pathophysiology to new treatments. Intensive Care Med 30(2):185\u2013196","journal-title":"Intensive Care Med"},{"issue":"6","key":"1009_CR41","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ahj.2015.02.017","volume":"169","author":"JL Grodin","year":"2015","unstructured":"Grodin JL, Drazner MH, Dupont M, Mullens W, Taylor DO, Starling RC, Tang WH (2015) A disproportionate elevation in right ventricular filling pressure, in relation to left ventricular filling pressure, is associated with renal impairment and increased mortality in advanced decompensated heart failure. Am Heart J 169(6):806\u2013812","journal-title":"Am Heart J"},{"issue":"2","key":"1009_CR42","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/CIRCHEARTFAILURE.112.000204","volume":"6","author":"MH Drazner","year":"2013","unstructured":"Drazner MH, Velez-Martinez M, Ayers CR, Reimold SC, Thibodeau JT, Mishkin JD, Mammen PP, Markham DW, Patel CB (2013) Relationship of right- to left-sided ventricular filling pressures in advanced heart failure: insights from the ESCAPE trial. Circ Heart Fail 6(2):264\u2013270","journal-title":"Circ Heart Fail"},{"issue":"6","key":"1009_CR43","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ejhf.289","volume":"17","author":"A Mebazaa","year":"2015","unstructured":"Mebazaa A, Yilmaz MB, Levy P, Ponikowski P, Peacock WF, Laribi S, Ristic AD, Lambrinou E, Masip J, Riley JP, McDonagh T, Mueller C, deFilippi C, Harjola VP, Thiele H, Piepoli MF, Metra M, Maggioni A, McMurray J, Dickstein K, Damman K, Seferovic PM, Ruschitzka F, Leite-Moreira AF, Bellou A, Anker SD, Filippatos G (2015) Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. Eur J Heart Fail 17(6):544\u2013558","journal-title":"Eur J Heart Fail"},{"issue":"14","key":"1009_CR44","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"JJ McMurray","year":"2012","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A (2012) Guidelines ESCCfP. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787\u20131847","journal-title":"Eur Heart J"},{"issue":"13","key":"1009_CR45","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jacc.2007.08.072","volume":"51","author":"A Nohria","year":"2008","unstructured":"Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA (2008) Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 51(13):1268\u20131274","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1009_CR46","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ahj.2009.03.007","volume":"157","author":"SJ Shah","year":"2009","unstructured":"Shah SJ, Blair JE, Filippatos GS, Macarie C, Ruzyllo W, Korewicki J, Bubenek-Turconi SI, Ceracchi M, Bianchetti M, Carminati P, Kremastinos D, Grzybowski J, Valentini G, Sabbah HN, Gheorghiade M, HORIZON-HF Investigators (2009) Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial. Am Heart J 157(6):1035\u20131041","journal-title":"Am Heart J"},{"issue":"12","key":"1009_CR47","first-page":"1531","volume":"287","author":"VMAC Investigators","year":"2012","unstructured":"VMAC Investigators (2002) Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 287(12):1531\u20131540","journal-title":"JAMA"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-016-1009-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-016-1009-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-016-1009-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:33:08Z","timestamp":1498307588000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-016-1009-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,17]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1009"],"URL":"https:\/\/doi.org\/10.1007\/s00392-016-1009-6","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,17]]}}}